VENTURE CAPITAL &
CROSS - BORDER INVESTMENT
Ivy Elite Capital (as IEC) is a venture capital firm that identifies and develops investment opportunities in the Life Science and Clean Tech Industries. IEC is committed to providing capital, strategic and operational expertise to late stage medical companies (M&A or pre-IPO) and growth stage Clean Tech companies seeking to expand into international markets particularly the Greater China.
We seek to partner with outstanding individuals who have created exceptional companies in order to develop world class industry leaders.
IEC believes in agile and dynamic decision-making to resource our investee companies in a timely and effective manner. We provide resources, strategic and operational support as and when required but trust our management partners to execute on our collective ambitious growth plans.
One of IEC’s advantages is its Founders’ deep understanding of cultural differences and the need to be respectful of local markets, cultures and government relations. IEC guides its clients and portfolio companies in developing a culturally appropriate strategy for each expansion market to give them the best chance of success.